Drawing for ARKRAY

USPTO serial 79094092

ARKRAY

Reviewed by CopyMark Law Group

Reg. 4085861Status 706Registered
Filing date
Status date
Registration date
Jan 17, 2012
Examiner
SEVERSON, KAREN
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ARKRAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Olsen

Michael T. Olsen Winthrop & Weinstine, P.A.225 South Sixth StreetCapella Tower, Suite 3500Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diabetes, [arteriosclerosis, cancer, cancer metastasis, high blood pressure, skin disease, arthritis, asthma, and allergy; ] medical diagnostic reagents; reagents for medical and clinical diagnostic purposes; Diagnostic preparations for medical purposes; [ medical and veterinary reagents for use in medical genetic testing; reagents comprising gene chips used for clinical diagnosis for medical and diagnostic purposes; medical diagnostic reagents used for diagnosing certain diseases by analyzing the patterns of gene expression with DNA chips and protein chips; medical and veterinary diagnostic reagent kits for immunodiagnosis comprising gene and protein for medical and veterinary use; clinical medical and veterinary reagents for genetic detection of food poisoning bacteria; ] chemical reagents for medical and veterinary purposes; analytical reagents for medical purposes; medical reagents for analyzing components of body fluids, blood and urine; medical diagnostic reagents for urine analysis; medical diagnostic reagents for blood analysis; medical diagnostic reagents for analyzing electrolyte in body fluid; [ medical diagnostic reagents for immunoassay analysis; ] medical diagnostic reagents for measuring glucose; [ medical diagnostic reagents for measuring glycohemoglobin; medical diagnostic reagents for measuring ammonia; ] medical diagnostic test strips for urine analysis; medical diagnostic test strips for blood analysis; [ dietetic food preparations adapted for medical purposes; micro capsules sold empty for administering medicine, gene and other diagnostic products or preparations internally; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods consisting primarily of plants for medical purposes; dietetic processed foods adapted for medical purposes; oiled paper for medical purposes, namely, for wound dressing; capsules sold empty for pharmaceutical purposes; gauze for dressings; empty capsules for pharmaceuticals; adhesive bandages for ears; eye patches for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for use as sanitary napkins; adhesive medical plasters; bandages for dressings ]ACTIVE
009[ Laboratory devices for genetic testing, namely, for detecting genetic sequences; ] electronic products for the analysis of optical signals, namely, optical analyzers; [ food analyzers for measuring of nutritional components and the amount of pesticide residue in food; ] electronic instruments, namely, chemical composition analyzers; [ computer operating programs, recorded; downloadable computer programs in the nature of computer game software downloadable from a global computer network; recorded computer software, namely, computer game software; downloadable electronic publications in the nature of magazines in the field of computers and computer software; computer software for use in medical data management, recorded; downloadable computer programs for use in medical data management; video game machines for use with an external display screen or monitor; electronic publications in the nature of slide shows in the field of medical education ]ACTIVE
010Medical apparatus and instruments, namely, medical diagnostic instruments for the analysis of body fluids and parts therefor; blood analyzers for medical purposes and parts therefor; automated biochemical analyzers for medical purposes and parts therefor; diagnostic apparatus for urine analysis for the detection of diabetes and parts therefor; medical apparatus for measuring glycated hemoglobin and parts therefor; [ medical apparatus for determining osmotic pressure and parts therefor; blood gas analyzers for medical purposes and parts therefor; ] medical apparatus for drawing blood samples; blood glucose meters and parts therefor; sensors for monitoring blood glucose level as part of blood glucose meters; medical apparatus for drawing blood, namely, puncture apparatus and parts for positioning of puncture; lancets; lancets for blood drawing; [ surgical apparatus and instruments for medical, dental, and veterinary use; ] veterinary apparatus and instruments, namely, veterinary diagnostic apparatus and instruments for analyzing blood, urine, and other bodily fluids; [ artificial tympanic membranes; artificial materials for use in the replacement of bones; electric massage apparatus for household use; gloves for medical purposes; urinals for medical purposes; bed pans; contraceptives, non-chemical; ear picks; sanitary masks for medical purposes ]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Apr 5, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 5, 2023INPCINVALIDATION PROCESSED
Feb 13, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 13, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 13, 202271AGREGISTERED-SEC.71 ACCEPTED
Jun 7, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2022ES71TEAS SECTION 71 RECEIVED
Jan 17, 2021REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 24, 2020RNWLINTERNATIONAL REGISTRATION RENEWED
Sep 27, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2018NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Aug 21, 2018C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Aug 16, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 31, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 1, 2018PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jan 17, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 11, 2018ES75TEAS SECTION 71 & 15 RECEIVED
Jan 17, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 7, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 15, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 15, 2012FIMPFINAL DISPOSITION PROCESSED
Apr 17, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 17, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 1, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 21, 2011ALIEASSIGNED TO LIE
Sep 7, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2011RFNTREFUSAL PROCESSED BY IB
Mar 25, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 25, 2011RFRRREFUSAL PROCESSED BY MPU
Mar 25, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 24, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Mar 18, 2011DOCKASSIGNED TO EXAMINER
Mar 18, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance